Matt Ranaghan is a Senior Applications Scientist at Refeyn, where he develops mass photometry solutions for characterizing proteins, nucleic acids, and lipid nanoparticles. He has over 10 years of industry experience in small-molecule drug discovery and the development of gene editing technologies. Matt holds a PhD in Biochemistry from the University of Connecticut, where he studied the application of photoactive proteins in biophotonic devices.